Online citations, reference lists, and bibliographies.
← Back to Search

Transscleral Drug Delivery For Posterior Segment Disease.

D. Geroski, H. Edelhauser
Published 2001 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Exciting new treatments are being developed for retinal degenerations and posterior segment eye disease. The successful treatment of these visually devastating diseases will likely require delivering effective doses of pharmacologic agents to the posterior segment, possibly in conjunction with surgical or genetic interventions. Currently, the treatment of diseases affecting the posterior segment is limited by the difficulty in delivering effective doses of drugs to target tissues in the posterior vitreous, retina or choroid. This review summarizes recent laboratory and clinical studies that indicate that transscleral delivery of therapeutic solutes might be an effective means of achieving therapeutic concentrations of these agents in the posterior eye.
This paper references
Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.
T. Olsen (1995)
10.1016/S0161-6420(00)00344-4
Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose.
O. Weijtens (2000)
10.1016/0002-9394(77)90741-3
Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit.
M. Barza (1977)
10.1021/IE9800952
Measurement and Prediction of Transient Transport across Sclera for Drug Delivery to the Eye
M. Prausnitz (1998)
10.1248/CPB.32.4205
Pluronic F-127 gels as a vehicle for topical administration of anticancer agents.
S. Miyazaki (1984)
10.1016/S0002-9394(14)70131-X
Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection.
O. Weijtens (1997)
10.1021/JS9802594
Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.
M. Prausnitz (1998)
10.1016/S0002-9394(98)00003-8
Dexamethasone concentration in vitreous and serum after oral administration.
O. Weijtens (1998)
10.1016/S0002-9394(14)75252-3
Intraocular penetration of gentamicin after subconjunctibal and retrobulbar injection .
M. Barza (1978)
10.1016/S0002-9394(99)80096-8
Human sclera: thickness and surface area.
T. Olsen (1998)
Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
I. Ahmed (1985)
Transscleral delivery of bioactive protein to the choroid and retina.
J. Ambati (2000)
10.1001/ARCHOPHT.1965.00970040250024
MOVEMENT OF ALBUMIN AND DEXTRAN THROUGH THE SCLERA.
A. Bill (1965)
Diffusion of high molecular weight compounds through sclera.
J. Ambati (2000)
10.1001/ARCHOPHT.1988.01060140266039
Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.
H. Edelhauser (1988)
10.1016/0168-3659(95)00139-5
Development of a local antibiotic delivery system using fibrin glue
B. Yu (1996)
10.1002/AIC.690440123
Fiber matrix model of sclera and corneal stroma for drug delivery to the eye
A. Edwards (1998)
10.1016/0014-4835(75)90057-3
Proteoglycans and collagen fibre organization in human corneoscleral tissue.
M. S. Borcherding (1975)
10.1016/0169-409X(95)00012-V
Ocular drug delivery conventional ocular formulations
John C. Lang (1995)
The effect of intraocular pressure on human and rabbit scleral permeability.
D. E. Rudnick (1999)
10.1016/S0002-9394(99)00129-4
High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection.
O. Weijtens (1999)
10.1016/0014-4835(77)90136-1
Diffusion across the sclera.
D. Maurice (1977)



This paper is referenced by
10.1590/S0004-27492010000300018
Farmacologia ocular aplicada no tratamento de doenças do vítreo, retina e coróide
P. Filho (2010)
10.1016/B978-012369415-7/50019-3
18 – Neurotrophic Cell Transplants for Degenerative Diseases of the Eye
C. Thanos (2007)
[Ocular pharmacology in the treatment of vitreous, retina and choroid diseases].
P. A. Filho (2010)
10.1097/IAE.0000000000001826
Evolving Role of Regional Depot Corticosteroids in Management of Diabetic Macular Edema
S. Kim (2017)
10.1016/j.actbio.2016.08.011
Microneedle-based minimally-invasive measurement of puncture resistance and fracture toughness of sclera.
S. H. Park (2016)
10.1089/TEN.2004.10.1617
Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device.
C. Thanos (2004)
10.1167/IOVS.05-0283
Extraocular muscle insertions relative to the fovea and optic nerve: humans and rhesus macaque.
X. Feng (2005)
10.1167/iovs.08-2300
Exogenous collagen cross-linking reduces scleral permeability: modeling the effects of age-related cross-link accumulation.
J. Stewart (2009)
A Review on Local Chemotherapy for Treatment of Retinoblastoma
F. Ghassemi (2011)
10.2147/IJN.S105606
Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol.
Gladys Rosario Ramos Yacasi (2016)
10.1186/1471-2415-8-5
Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema
M. Cellini (2008)
10.1007/978-3-319-29346-2_18
Intraocular Drug Delivery Technologies: Advancing Treatment of Posterior Segment Disorders of the Eye
V. Pillay (2016)
Drug Delivery to the Posterior Eye Using Etched Microneedles
Geetha Mahadevan (2011)
10.1016/S0014-4835(03)00053-8
Differential effects of aging on transport properties of anterior and posterior human sclera.
O. Boubriak (2003)
Chapter 2 Design , Development and Evaluation of Nanoparticulate Based Carrier Systems for Ocular Drug delivery
(2015)
Echography-Verified Retrobulbar Triamcinolone Injection in the Treatment of Uveitis
M. Gamal (2013)
10.1115/1.4048481
Hydrogel-Forming Microneedle Arrays for Sustained and Controlled Ocular Drug Delivery
Maher Amer (2020)
10.1016/j.actbio.2013.09.022
Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix.
Yongchun Meng (2014)
10.1080/10717544.2017.1324531
Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit
Xuetao Huang (2017)
10.3390/12030373
Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.
Abeer M. Al-Ghananeem (2007)
10.1201/9780429201400-13
Development of ophthalmic formulations
Paramita Bandyopadhyay (2016)
10.17925/EE.2012.08.01.42
Triamcinolone Acetonide for the Treatment of Diabetic Macular Oedema
V. Sarao (2010)
10.1001/archophthalmol.2009.352
Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
J. Cardillo (2010)
10.1016/j.medengphy.2020.06.005
A drug delivery analysis of large molecules in ocular vitreous chamber: Dependency on saccadic movements after intravitreal injection.
M. Ferroni (2020)
10.1016/j.ijpharm.2010.09.001
Ultrasound-enhanced intrascleral delivery of protein.
Alex Cheung (2010)
10.1016/j.ijpharm.2017.02.044
Parameters affecting the transscleral delivery of two positively charged proteins of comparable size.
M. A. Grimaudo (2017)
Introduction: To evaluate the changes of scleral thickness after repeated intravitreal injections of bevacizumab in a consecutive series of patients with anterior segment optical coherence tomog-
ELİAÇIK (2018)
Biopharmaceutical approaches for improved drug delivery across ocular barriers
Ketan Hippalgaonkar (2011)
10.1002/jps.21987
A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Y. Choonara (2010)
10.1016/j.drudis.2019.04.002
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
H. Gukasyan (2019)
10.1007/978-3-319-29346-2_9
Ocular Permeation Enhancers
N. Kim (2016)
10.1016/j.exer.2014.02.001
Cholesterol-poly(ethylene) glycol nanocarriers for the transscleral delivery of sirolimus.
N. Elsaid (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar